Oxford BioTherapeutics Announces Research Collaboration with

/PRNewswire/ -- Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based...

Related Keywords

United Kingdom , United States , Wuxi , Jiangsu , China , Eleanor Perkin , Oxford Biotherapeutics , George Underwood , Alere Abbott , Stacy Coen , Christian Rohlff , Sylvie Berrebi , Amgen , Boehringer Ingelheim , Antibody Drug Conjugates , Antibody Drug Conjugate , Chief Executive Officer , Senior Vice President , Chief Business , San Jose , Kite Pharma , David Dible ,